Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Follicular 2 Pulmonary Disease, Chronic Obstructive 1 Myasthenia Gravis 1 Asthma 1

Interventions

rozanolixizumab 10 zilucoplan 8 efgartigimod alfa 8 Rituximab 7 Cyclophosphamide 7 telitacicept 6 fludarabine 6 eculizumab 5 Prednisone 5 ravulizumab 4 Pyridostigmine Bromide 4 Immunoglobulins, Intravenous 4 Hizentra 4 Tacrolimus 3 Mycophenolic Acid 3 HBM9161 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Prednisolone 2 Exercise 2 tofacitinib 1 tocilizumab 1 talquetamab 1 satralizumab 1 sargramostim 1 rhoA GTP-Binding Protein 1 remibrutinib 1 prednylidene 1 iscalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Myasthenia Gravis × Albuterol × Clear all

NCT03914638 2020-04-06

BETA-MG

University of Aarhus

Phase 2/3 Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡